Paper25529348
Gateway-compatible vectors for high-throughput protein expression in pro- and eukaryotic cell-free systems.
Gagoski D and 7 others. J Biotechnol, 2015. Cited by 36 papers, by iCite.
Cite this record
ConductScience Library. Gateway-compatible vectors for high-throughput protein expression in pro- and eukaryotic cell-free systems. Papers, record 25529348. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25529348
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Gateway-compatible vectors for high-throughput protein expression in pro- and eukaryotic cell-free systems.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell-Free System | Major topic |
| Cloning, Molecular | Major topic |
| Genetic Vectors | Major topic |
| Protein Engineering | Major topic |
| Recombinant Proteins | Major topic |
| Escherichia coli | |
| Humans | |
| Leishmania | |
| Nucleic Acid Amplification Techniques |
Source PubMed
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40947650 | Reconstitution of Human Cytochrome P450 Activity using a Leishmania Cell-Free Protein Expression System. | ACS Synth Biol | 2025 | https://conductscience.org/library/papers/40947650 | PubMed |
| 39700225 | Cell-Free Gene Expression: Methods and Applications. | Chem Rev | 2025 | https://conductscience.org/library/papers/39700225 | PubMed |
| 39373325 | An Automated Cell-Free Workflow for Transcription Factor Engineering. | ACS Synth Biol | 2024 | https://conductscience.org/library/papers/39373325 | PubMed |
| 38267582 | The HIV capsid mimics karyopherin engagement of FG-nucleoporins. | Nature | 2024 | https://conductscience.org/library/papers/38267582 | PubMed |
| 37483225 | In Vitro Reconstitution and Analysis of SARS-CoV-2/Host Protein-Protein Interactions. | ACS Omega | 2023 | https://conductscience.org/library/papers/37483225 | PubMed |
| 34874911 | Non-beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma. | J Clin Invest | 2022 | https://conductscience.org/library/papers/34874911 | PubMed |
| 34556785 | Selectivity of Lewy body protein interactions along the aggregation pathway of α-synuclein. | Commun Biol | 2021 | https://conductscience.org/library/papers/34556785 | PubMed |
| 33972532 | MyD88 TIR domain higher-order assembly interactions revealed by microcrystal electron diffraction and serial femtosecond crystallography. | Nat Commun | 2021 | https://conductscience.org/library/papers/33972532 | PubMed |
| 33904409 | A robust method for particulate detection of a genetic tag for 3D electron microscopy. | Elife | 2021 | https://conductscience.org/library/papers/33904409 | PubMed |
| 33842544 | Easy Synthesis of Complex Biomolecular Assemblies: Wheat Germ Cell-Free Protein Expression in Structural Biology. | Front Mol Biosci | 2021 | https://conductscience.org/library/papers/33842544 | PubMed |
| 31827096 | Single-molecule detection on a portable 3D-printed microscope. | Nat Commun | 2019 | https://conductscience.org/library/papers/31827096 | PubMed |
| 31358114 | R-propranolol is a small molecule inhibitor of the SOX18 transcription factor in a rare vascular syndrome and hemangioma. | Elife | 2019 | https://conductscience.org/library/papers/31358114 | PubMed |
| 30583727 | Pathological mutations differentially affect the self-assembly and polymerisation of the innate immune system signalling adaptor molecule MyD88. | BMC Biol | 2018 | https://conductscience.org/library/papers/30583727 | PubMed |
| 30335167 | Homodimerization regulates an endothelial specific signature of the SOX18 transcription factor. | Nucleic Acids Res | 2018 | https://conductscience.org/library/papers/30335167 | PubMed |
| 29648920 | Functional domain analysis of SOX18 transcription factor using a single-chain variable fragment-based approach. | MAbs | 2018 | https://conductscience.org/library/papers/29648920 | PubMed |
| 29621251 | Ultrastructural localisation of protein interactions using conditionally stable nanobodies. | PLoS Biol | 2018 | https://conductscience.org/library/papers/29621251 | PubMed |
| 29364143 | Unveiling a Selective Mechanism for the Inhibition of α-Synuclein Aggregation by β-Synuclein. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/29364143 | PubMed |
| 28759049 | Structural basis of TIR-domain-assembly formation in MAL- and MyD88-dependent TLR4 signaling. | Nat Struct Mol Biol | 2017 | https://conductscience.org/library/papers/28759049 | PubMed |
| 28137359 | Pharmacological targeting of the transcription factor SOX18 delays breast cancer in mice. | Elife | 2017 | https://conductscience.org/library/papers/28137359 | PubMed |
| 27892477 | Nanomolar oligomerization and selective co-aggregation of α-synuclein pathogenic mutants revealed by single-molecule fluorescence. | Sci Rep | 2016 | https://conductscience.org/library/papers/27892477 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25529348
GET https://conductscience.org/api/papers/v1/25529348/cited_by?page=2